Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh.

NCT00143208 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

250

Enrollment

INDUSTRY

Sponsor class

Conditions

Glaucoma
Ocular Hypertension

Interventions

DRUG: Xalacom

Sponsor

Pfizer's Upjohn has merged with Mylan to form Viatris Inc.